查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1961337

血小板凝集裝置市場 - 全球產業規模、佔有率、趨勢、機會、預測：按產品類型、應用、最終用戶、地區和競爭對手分類，2021-2031年

Platelet Aggregation Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Application, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球血小板凝集裝置市場預計將從 2025 年的 9.2268 億美元成長到 2031 年的 12.5211 億美元，複合年成長率為 5.22%。

這些專用診斷設備旨在評估血小板聚集和形成血栓的能力，在評估止血功能和確定抗血小板治療效果方面發揮著至關重要的作用。推動市場成長的關鍵因素包括全球心血管疾病發生率的上升，以及由此導致的臨床和外科手術中對嚴格血小板功能檢查需求的增加。此外，人口老化使得定期監測血栓風險成為必要，從而維持了對這些診斷系統的穩定需求。根據英國心臟基金會的數據，2023年心血管和循環系統疾病約佔全球所有死亡人數的三分之一。

市場概覽
預測期 2027-2031
市場規模：2025年 9.2268億美元
市場規模：2031年 1,252,110,000 美元
複合年成長率：2026-2031年 5.22%
成長最快的細分市場 耗材和配件
最大的市場 北美洲

然而，限制該市場更廣泛擴張的一大挑戰是先進的自動化凝集檢測系統及其維護成本高成本。這些經濟負擔構成了一大障礙，尤其對於發展中地區的小規模診所和醫療機構而言，使得投資此類專用設備變得困難。因此，這些經濟限制阻礙了市場滲透，並限制了資源匱乏地區快速血小板功能檢查的普及。

市場促進因素

慢性病和心血管疾病的日益普遍是推動血小板凝集分析儀普及應用的主要動力。隨著中風和冠狀動脈疾病等疾病在全球範圍內負擔加重，臨床檢查室正將嚴格的血小板功能檢查作為優先事項，旨在更好地管理抗血小板治療並最大限度地降低血栓風險。這對於接受介入治療的患者尤其重要，因為監測止血功能對於預防出血和支架血栓症等不利事件至關重要。根據美國心臟協會於2024年1月發布的《2024年心臟病和中風統計數據》，約48.6%的美國成年人患有某種形式的心血管疾病，凸顯了對這一大規模患者群體進行有效診斷監測的緊迫性。

同時，老年人口的快速成長是市場需求的主要驅動力。這是因為老年人更容易罹患血小板相關疾病，且通常需要長期服藥。在高齡化社會中，頻繁的診斷篩檢對於調整治療方案和確保複雜手術期間的病人安全至關重要。根據世界衛生組織（世衛組織）於2024年5月發布的《2024年世界衛生統計》，全球60歲以上人口預計將從2023年的11億增加到2030年的14億。為因應人口結構變化帶來的介入技術需求，領先的醫療科技公司正呈現強勁成長動能。雅培公司在2024年10月公佈，第三季全球醫療設備銷售額成長了11.7%。

市場挑戰

先進的自動化血小板聚集檢測系統的實施和維護成本高昂，是限制全球血小板凝集檢測市場成長的主要障礙。這些設備需要大量的初始投資，因此難以推廣應用，尤其對於預算有限的發展中地區的小規模診所和醫療機構而言更是如此。除了購置成本外，校準、專用試劑和技術服務等持續性費用也進一步加重了診斷中心的營運負擔。因此，經濟負擔限制了現代血小板功能檢查的應用，使其僅限於資金雄厚的大型醫院，導致相當一部分潛在市場尚未開發。

診斷服務提供者日益惡化的財務環境進一步加劇了這種經濟壓力。據美國診斷和臨床實驗室醫師協會 (ADLM) 稱，擬議削減高達 15% 的聯邦醫療保險 (Medicare) 對關鍵診斷測試的支付，將為臨床檢查室在 2024 年帶來巨大的財務不確定性。此類報銷限制嚴重限制了可用於基礎設施升級的資金。因此，醫療機構不太可能投資昂貴的自動化系統，這直接阻礙了這些關鍵診斷設備的市場滲透。

市場趨勢

隨著醫療機構努力解決人員短缺問題並應對日益成長的檢測量，向自動化、高通量檢測系統的轉變正在重塑全球血小板凝集)分析儀市場。檢查室正逐步摒棄勞力密集的手動光透射凝集檢測法，轉而採用整合式止血工作站，從而簡化檢體處理和數據管理。這種轉變不僅提高了工作流程效率，還實現了大規模醫療網路內檢測結果的標準化，減少了傳統方法中固有的操作者差異。市場領導的財務表現也印證了對擴充性自動化解決方案的需求。根據 Warfen 於 2025 年 3 月發布的《2024 年年度報告》，其止血部門在 2024 年實現了 6.6% 的收入成長，這主要得益於專業自動化和資料管理解決方案的應用。

同時，機器學習 (ML) 和人工智慧 (AI) 的融合正在革新對複雜血小板功能數據的解讀。製造商正將 AI 演算法整合到診斷軟體中，以更精確地分析血小板聚集曲線，從而能夠早期發現可能預示血栓風險或對抗血小板治療無反應的異常情況。這些先進的分析工具透過提供預測性見解來支持臨床決策，並有助於為心血管疾病患者制定更個人化的治療策略。支持這項技術的監管環境也在快速發展。根據《醫療未來學家》(The Medical Futurist) 於 2025 年 7 月發布的關於 FDA核准的AI醫療設備的報告，僅在 2025 年上半年，FDA 就批准了 148 種新的 AI 設備，這表明智慧診斷技術的部署正在加速推進。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球血小板凝集裝置市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品類型（系統/設備、耗材/配件）
    • 依用途（臨床用途、外包）
    • 依最終使用者（醫院、診斷中心、研究機構、學術機構）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美血小板凝集裝置市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲血小板凝集儀市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區血小板凝集裝置的市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲血小板凝集裝置的市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲血小板凝集裝置的市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球血小板凝集裝置市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • AggreDyne, Inc.
  • Bio/Data Corporation
  • Chrono-Log Corporation
  • F. Hoffmann-La Roche Ltd.
  • Haemonetics Corporation
  • Siemens Healthineers AG
  • Werfen, SA
  • Sysmex Corporation
  • Sienco, Inc.
  • Drucker Diagnostics

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 24017

The Global Platelet Aggregation Devices Market is projected to expand from USD 922.68 Million in 2025 to USD 1252.11 Million by 2031, registering a CAGR of 5.22%. These specialized diagnostic instruments are designed to assess the ability of thrombocytes to cluster and form clots, which is fundamental for evaluating hemostasis and determining the effectiveness of antiplatelet therapies. Key drivers fueling this market growth include the rising global incidence of cardiovascular conditions and the subsequent need for rigorous platelet function testing in both clinical and surgical settings. Furthermore, the expanding geriatric population necessitates regular monitoring for thrombotic risks, thereby maintaining a steady demand for these diagnostic systems. Data from the British Heart Foundation indicates that in 2023, circulatory and cardiovascular diseases were responsible for approximately one-third of all global deaths.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 922.68 Million
Market Size 2031USD 1252.11 Million
CAGR 2026-20315.22%
Fastest Growing SegmentConsumables & Accessories
Largest MarketNorth America

However, a significant challenge limiting the broader expansion of this market is the high cost linked to advanced automated aggregometry systems and their required maintenance. These financial demands pose a barrier for smaller clinics and healthcare facilities, particularly in developing regions, making it difficult to invest in such specialized equipment. Consequently, these economic constraints hinder market penetration and restrict the availability of rapid platelet function testing in resource-limited environments.

Market Driver

The increasing prevalence of chronic and cardiovascular diseases serves as a primary catalyst for the adoption of platelet aggregation devices. As the global burden of conditions such as stroke and coronary artery disease grows, clinical laboratories are prioritizing rigorous platelet function testing to manage antiplatelet therapies and minimize thrombotic risks. This is especially critical for patients undergoing interventional procedures, where monitoring hemostasis is vital to prevent adverse events like bleeding or stent thrombosis. According to the American Heart Association's "Heart Disease and Stroke Statistics-2024 Update" from January 2024, approximately 48.6% of adults in the United States have some form of cardiovascular disease, highlighting the urgent need for effective diagnostic monitoring for this large patient population.

Simultaneously, the rapid expansion of the geriatric population significantly drives market demand, as elderly individuals are more susceptible to platelet-related disorders and often require chronic medication management. An aging demographic necessitates frequent diagnostic screenings to adjust therapeutic regimens and ensure patient safety during complex surgeries. According to the World Health Organization's "World Health Statistics 2024" released in May 2024, the global population aged 60 years and older is expected to rise from 1.1 billion in 2023 to 1.4 billion by 2030. Reflecting the demand for interventional technologies driven by these demographic shifts, major medtech companies are seeing strong growth; Abbott Laboratories reported in October 2024 that global medical device sales increased by 11.7% on a reported basis in the third quarter.

Market Challenge

The substantial cost associated with acquiring and maintaining advanced automated aggregometry systems represents a major obstacle to the growth of the Global Platelet Aggregation Devices Market. These instruments require a significant initial capital investment, which is often prohibitive for smaller clinics and healthcare facilities, particularly in developing regions with limited budgets. Beyond the purchase price, recurring expenses for calibration, specialized reagents, and technical servicing further strain the operational finances of diagnostic centers. As a result, the financial burden limits the adoption of modern platelet function testing primarily to large, well-funded hospitals, leaving a significant portion of the potential market untapped.

This economic pressure is exacerbated by a tightening financial landscape for diagnostic providers. According to the Association for Diagnostics & Laboratory Medicine, clinical laboratories faced significant fiscal uncertainty in 2024 due to proposed Medicare payment reductions of up to 15% for key diagnostic tests. Such constraints on reimbursement rates severely limit the capital available for infrastructure upgrades. Consequently, facilities are less likely to invest in expensive automated systems, which directly hampers the broader market penetration of these critical diagnostic devices.

Market Trends

The shift toward automated high-throughput laboratory systems is reshaping the Global Platelet Aggregation Devices Market as facilities aim to address staffing shortages and handle increasing testing volumes. Laboratories are moving away from manual, labor-intensive light transmission aggregometry in favor of integrated hemostasis workcells that streamline sample processing and data management. This transition not only improves workflow efficiency but also standardizes results across large healthcare networks, reducing the inter-operator variability common in traditional methods. The demand for scalable, automated solutions is evident in the financial performance of market leaders; Werfen's "Annual Review 2024," published in March 2025, noted that its Hemostasis division achieved 6.6% revenue growth in 2024, driven significantly by the adoption of its specialized automation and data management solutions.

Concurrently, the integration of Machine Learning (ML) and Artificial Intelligence (AI) is revolutionizing the interpretation of complex platelet function data. Manufacturers are embedding AI algorithms into diagnostic software to analyze aggregation curves with greater precision, allowing for the early detection of anomalies that may indicate thrombotic risks or non-responsiveness to antiplatelet therapy. These advanced analytics tools support clinical decision-making by providing predictive insights, facilitating more personalized treatment strategies for cardiovascular patients. The regulatory landscape is rapidly evolving to support this technology; according to a July 2025 report by The Medical Futurist on FDA-approved AI-based medical devices, the FDA authorized 148 new AI-enabled devices in the first half of 2025 alone, signaling a robust acceleration in the deployment of intelligent diagnostic technologies.

Key Market Players

  • AggreDyne, Inc.
  • Bio/Data Corporation
  • Chrono-Log Corporation
  • F. Hoffmann-La Roche Ltd.
  • Haemonetics Corporation
  • Siemens Healthineers AG
  • Werfen, S.A.
  • Sysmex Corporation
  • Sienco, Inc.
  • Drucker Diagnostics

Report Scope

In this report, the Global Platelet Aggregation Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Platelet Aggregation Devices Market, By Product Type

  • Systems & Instruments
  • Consumables & Accessories

Platelet Aggregation Devices Market, By Application

  • Clinical Applications
  • Outsourced

Platelet Aggregation Devices Market, By End User

  • Hospital
  • Diagnostic Centers
  • Research
  • Academic Institutes

Platelet Aggregation Devices Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Platelet Aggregation Devices Market.

Available Customizations:

Global Platelet Aggregation Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Platelet Aggregation Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Systems & Instruments, Consumables & Accessories)
    • 5.2.2. By Application (Clinical Applications, Outsourced)
    • 5.2.3. By End User (Hospital, Diagnostic Centers, Research, Academic Institutes)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Platelet Aggregation Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Platelet Aggregation Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Platelet Aggregation Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Platelet Aggregation Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Platelet Aggregation Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Platelet Aggregation Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. France Platelet Aggregation Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Platelet Aggregation Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Platelet Aggregation Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Platelet Aggregation Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia Pacific Platelet Aggregation Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Platelet Aggregation Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Platelet Aggregation Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Platelet Aggregation Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Platelet Aggregation Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Platelet Aggregation Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. Middle East & Africa Platelet Aggregation Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Platelet Aggregation Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Platelet Aggregation Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Platelet Aggregation Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. South America Platelet Aggregation Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Platelet Aggregation Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Platelet Aggregation Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Platelet Aggregation Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Platelet Aggregation Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. AggreDyne, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Bio/Data Corporation
  • 15.3. Chrono-Log Corporation
  • 15.4. F. Hoffmann-La Roche Ltd.
  • 15.5. Haemonetics Corporation
  • 15.6. Siemens Healthineers AG
  • 15.7. Werfen, S.A.
  • 15.8. Sysmex Corporation
  • 15.9. Sienco, Inc.
  • 15.10. Drucker Diagnostics

16. Strategic Recommendations

17. About Us & Disclaimer